Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,494.00
Bid: 7,480.00
Ask: 7,483.00
Change: 76.00 (1.02%)
Spread: 3.00 (0.04%)
Open: 7,450.00
High: 7,507.00
Low: 7,422.00
Yest. Close: 7,418.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 1-First human trial of AstraZeneca COVID-19 vaccine shows promise

Mon, 20th Jul 2020 14:55

(Adds detail, background)

LONDON, July 20 (Reuters) - AstraZeneca's
experimental COVID-19 vaccine was safe and produced an immune
response in early-stage clinical trials in healthy volunteers,
data showed on Monday.

The vaccine, called AZD1222 and being developed by
AstraZeneca and scientists at Britain's University of Oxford,
did not prompt any serious side effects and elicited antibody
and T-cell immune responses, according to trial results
published in The Lancet medical journal.

"We hope this means the immune system will remember the
virus, so that our vaccine will protect people for an extended
period," study lead author Andrew Pollard of the University of
Oxford said.

"However, we need more research before we can confirm the
vaccine effectively protects against SARS-CoV-2 (COVID-19)
infection, and for how long any protection lasts," he said.

AstraZeneca's is among the leading vaccine candidates
against a pandemic that has claimed more than 600,000 lives,
alongside others in mid and late-stage trials.

These include shots being developed by China's Sinovac
Biotech, another from state-owned Chinese firm
Sinopharm, and one from the U.S. biotech firm Moderna.

AstraZeneca has signed agreements with governments around
the world to supply the vaccine should it prove effective and
gain regulatory approval. The company has said it will not seek
to profit from the vaccine during the pandemic.

Researchers said the vaccine caused minor side effects more
frequently than a control group, but some of these could be
reduced by taking paracetamol, with no serious adverse events
from the vaccine.
(Reporting by Alistair Smout; additional reporting by Pushkala
Aripaka and Kate Kelland; Editing by Edmund Blair and Mark
Potter)

More News

UPDATE 1-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says

(Adds details of collaboration, scientific paper)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with h...

20 Apr 21 20:35

UPDATE 2-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says

(Adds details on class of vaccines)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with him on the rese...

20 Apr 21 20:35

German scientist: J&J to cooperate in study of rare clots linked to COVID-19 vaccine

ZURICH, April 20 (Reuters) - A German scientist studying rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday that Johnson & Johnson had agreed to collaborate with him on research into similar events associated with its own C...

20 Apr 21 17:54

European Medicines Agency: More than 300 cases of rare blood clot events worldwide

AMSTERDAM, April 20 (Reuters) - The European Union's drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.There were 287 occur...

20 Apr 21 16:22

UPDATE 1-Mexico president receives AstraZeneca vaccine against COVID-19

(Adds context on AstraZeneca, quotes)MEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries limited the use of Ast...

20 Apr 21 15:54

UPDATE 2-Mexico president touts 'no risks' as he receives AstraZeneca vaccine

(Adds details on Mexico vaccine supply)By Daina Beth SolomonMEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries...

20 Apr 21 15:54

UPDATE 1-EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

(Adds details from EMA statement)April 20 (Reuters) - Europe's drug regulator said on Tuesday it had found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the Unite...

20 Apr 21 15:26

UPDATE 2-EU regulator backs J&J vaccine despite finding possible link to blood clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Writes through with details, background)April 20 (Reuters) - Europe's drug regulator has f...

20 Apr 21 15:26

UPDATE 3-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details, quotes from EMA news conference)By Pushkala Aripaka and Anthony DeutschApril...

20 Apr 21 15:26

UPDATE 4-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adding details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Re...

20 Apr 21 15:26

UPDATE 5-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Reut...

20 Apr 21 15:26

Mexico president receives AstraZeneca vaccine against COVID-19

MEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca vaccine against COVID-19 at his regular daily news conference on Tuesday.The 67-year-old, who had contracted the coronavirus in January, said ...

20 Apr 21 15:15

EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

April 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States, the watchdog said on Tuesday.(Reporting b...

20 Apr 21 15:12

UPDATE 1-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

(Adds details, background)By John MillerZURICH, April 20 (Reuters) - Switzerland's drug regulator is still awaiting data needed to consider AstraZeneca's COVID-19 vaccine candidate for approval, a Swissmedic official said on Tuesday, adding the in...

20 Apr 21 14:23

UPDATE 2-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

* Alpine nation has approved 3 COVID-19 vaccines, so far* Swiss expect 8 mln Q2 vaccine doses, despite Moderna hiccups (Adds detail in 6th paragraph about possible recommendation for AstraZeneca vaccine, following rare blood clots)By John MillerZU...

20 Apr 21 14:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.